Kimya Group

Having concentrated on Petrochemical to Pharmaceutical (P2P) chain development, Kimya Group was established to identify, evaluate and invest in the potential petrochemical, chemical and pharmaceutical projects. Building synergy among the subsidiaries via Know-How transfer and active collaboration is another role, through which Kimya Group is contributing to sustainable value creation. Kimyagaran Emrooz, Parand Darou and APIRA are considered as Kimya Groups subsidiaries in chemical and pharmaceutical sector. Established in 1995, Kimyagaran Emrooz among other companies, has become one of the biggest producers of APIs and strategic chemical products in Iran. Parand Darou, meanwhile, as the main subsidiary of Kimyagaran Emrooz is involved in production of Narcotic drugs with the vision of value chain development up to semi-finished & finished products. The forward integration strategy has also led another pharmaceutical company named APIRA to be acquired by Kimya Group. Petronad Asia, D...